Видео с ютуба Relapse Biology

Understanding the biology behind AML relapse

Relapse After SCT

CNS relapse in DLBCL: risk stratification, prophylaxis & treatment

CLL Remission and Relapse - A Thought Exercise

The Origin of Relapses MDS/AML - L Shlush

Relapsed and Refractory CLL/SLL

Central nervous system relapse of aggressive non-Hodgkin lymphoma

Using epigenetic analysis to understand the biology of relapse in AML

Relapse to cocaine seeking in a rat model: Behavioral and neuro-chemical mechanisms.

Recall Relapse

Relapsed and Refractory Diffuse Large B-Cell Lymphoma

AML relapse after HSCT: trends and predictive factors

Orca Bio: Redefining cell therapy, one cell at a time

Dr Graham Collins, Hodgkin Lymphoma - A Difficult Relapse at the BSH ASM, Glasgow 2016

Studying the evolution of acute myeloid leukemia (AML) relapse

Improving outcomes for patients who relapse after alloSCT & evaluating CD19 CARs against EMD in ALL

Using epigenetic strategies to combat relapse in patients with leukemia

Chronic Myeloid Leukaemia: new perspectives to prevent relapse of disease

Relapsed Lymphoma Professor Andrew Grigg

DLI following haploHCT PTCy relapse

Which MDS genetic mutations are most likely to cause relapse?

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Relapsed/Refractory B-cell Lymphomas in the CAR-T Era: Improving Outcomes in a Population at Need

Practice-Changing Data in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Cancer research discovery: pre-leukemic stem cell at root of AML, relapse